AGT and COVID-19: Pulmonary vasodilators such as inhaled nitric oxide, sildenafil, and angiotensin-(1,7) are currently involved in clinical trials for treatment of COVID-19 (e.g., ClinicalTrials.gov identifiers NCT04290871, NCT04304313, NCT04332666).